Assessment of anaemia in adults
91 results
1 - 91
Assessment of anaemia in adults - Assessment of anaemia in adults - Image
- Anaemia of chronic disease (ACD)
Androgens for the anaemia of chronic kidney disease in adults- Blood transfusion for treating malarial anaemia: Cochrane systematic review
- Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery
- Macrocytosis (increased MCV)
- Erythropoiesis‐stimulating agents for anaemia in adults with chronic kidney disease: a network meta‐analysis
- Sickle cell anaemia
- Darbepoetin for the anaemia of chronic kidney disease
- Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews
- Fatigue
- Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
- Iron therapy in anaemic adults without chronic kidney disease: Cochrane systematic review
- Blood transfusions for anaemia in patients with advanced cancer: Cochrane systematic review
- Iron therapy for preoperative anaemia
- Darbepoetin and biosimilars for the anaemia of chronic kidney disease
- Acute leukaemias in adults
- Fortification of maize flour with iron for controlling anaemia and iron deficiency in populations: Cochrane systematic review
- Iron supplementation for improving prevalence of anaemia and iron status in menstruating women
- Fortification of condiments and seasonings with iron for preventing anaemia and improving health
- Dyspnoea
- Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
- Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
- Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease
- Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron and iodine status
- Folate supplementation in people with sickle cell disease
- Carnitine supplements for people with chronic kidney disease requiring dialysis
- Antihelminthics in helminth‐endemic areas: effects on HIV disease progression
- Mental disorders during pregnancy
- Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
- Interventions for treating iron deficiency anaemia in inflammatory bowel disease
- Antenatal clinics: care and examinations
- Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews
- Transfusion of red blood cells stored for shorter versus longer duration for all conditions: Cochrane systematic review
- Erythropoietin or darbepoetin for patients with malignant disease
- Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients
- Blood transfusion: indications, administration and adverse reactions
- Zinc supplements for treating thalassaemia and sickle cell disease
- Dipyrone for acute primary headaches: Cochrane systematic review
- Hydroxyurea (hydroxycarbamide) for sickle cell disease
- House modifications for preventing malaria
- ADHD
- Parenteral versus oral iron therapy for adults and children with chronic kidney disease
- Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
- Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
- Phytomedicines (medicines derived from plants) for sickle cell disease
- Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
- Effects of all‐trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non‐acute promyelocytic leukaemia (non‐APL))
- Intravenous iron therapy for non‐anaemic, iron‐deficient adults
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
- Fortification of wheat and maize flour with folic acid for population health outcomes
- Digital tracking, provider decision support systems, and targeted client communication via mobile devices to improve primary health care
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
- Interventions for necrotizing soft tissue infections in adults
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
- Assessment and treatment of a patient with bleeding diathesis
- Mosquito aquatic habitat modification and manipulation interventions to control malaria
- Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population
- Growth hormone therapy for people with thalassaemia
- Indoor residual spraying for preventing malaria in communities using insecticide‐treated nets
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine
- Aerobic physical exercise for adult patients with haematological malignancies
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease
- Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
- Transfusion thresholds for guiding red blood cell transfusion
- Anxiety disorder
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas
- Vaccinations
- Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome
- Treatment for HIV‐associated cryptococcal meningitis
- Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery
- Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
- Hereditary coagulation factor deficiencies